Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate
ackground: Escherichia coli is one of the most important bacterial pathogen that can cause several disease to human being . In our study we try to investigate the sensitivity resistance pattern of Escherichia coli against three antibiotics ( Amikacin, Nalidixic acid and Cephalexin). Methods: For th...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Baghdad/ Al-Kindy College of Medicine
2010-06-01
|
| Series: | مجله كليه طب الكندي |
| Subjects: | |
| Online Access: | https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/696 |
| _version_ | 1798002195989266432 |
|---|---|
| author | Saad B. Nashtar Adel . H Sheeh |
| author_facet | Saad B. Nashtar Adel . H Sheeh |
| author_sort | Saad B. Nashtar |
| collection | DOAJ |
| description |
ackground: Escherichia coli is one of the most
important bacterial pathogen that can cause several
disease to human being . In our study we try to
investigate the sensitivity resistance pattern of
Escherichia coli against three antibiotics ( Amikacin,
Nalidixic acid and Cephalexin).
Methods: For this purpose we collected 51 clinical
isolates of Escherichia coli from stool and urine of
outpatient and inpatient patients from different wards
of AL-SADER Teaching Hospital in AL-NAJAF
AL-ASHRAf, IRAQ, and tested by culture and
sensitivity test .
Results: The results appeared that Amikacin show
the highest percentage of sensitivity ( 66.66 % ) ,
while Cephalexin show the lowest percentage of
sensitivity ( 6.34 % ) .
Conclusions: we conclude that Amikacin is the most
sensitive antibacterial drug for Escherichia Coli as
compared with Nalidixic acid and Cephalexin, while
Cephalexin is the most resistant antibacterial drug
for Escherichia Coli as compared with Amikacin and
Nalidixic acid.
|
| first_indexed | 2024-04-11T11:48:17Z |
| format | Article |
| id | doaj.art-fabfc0852b0a4b148d1c3ffdbe0d0b59 |
| institution | Directory Open Access Journal |
| issn | 1810-9543 2521-4365 |
| language | English |
| last_indexed | 2024-04-11T11:48:17Z |
| publishDate | 2010-06-01 |
| publisher | University of Baghdad/ Al-Kindy College of Medicine |
| record_format | Article |
| series | مجله كليه طب الكندي |
| spelling | doaj.art-fabfc0852b0a4b148d1c3ffdbe0d0b592022-12-22T04:25:28ZengUniversity of Baghdad/ Al-Kindy College of Medicineمجله كليه طب الكندي1810-95432521-43652010-06-0161Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorateSaad B. Nashtar0Adel . H Sheeh1Dept. of Pharmacology ,AL-Kindy College of Medicine, University of BaghdadDept. of Pharmacology and Therapeutics . College of Medicine. University of AL- Qadisiyah. ackground: Escherichia coli is one of the most important bacterial pathogen that can cause several disease to human being . In our study we try to investigate the sensitivity resistance pattern of Escherichia coli against three antibiotics ( Amikacin, Nalidixic acid and Cephalexin). Methods: For this purpose we collected 51 clinical isolates of Escherichia coli from stool and urine of outpatient and inpatient patients from different wards of AL-SADER Teaching Hospital in AL-NAJAF AL-ASHRAf, IRAQ, and tested by culture and sensitivity test . Results: The results appeared that Amikacin show the highest percentage of sensitivity ( 66.66 % ) , while Cephalexin show the lowest percentage of sensitivity ( 6.34 % ) . Conclusions: we conclude that Amikacin is the most sensitive antibacterial drug for Escherichia Coli as compared with Nalidixic acid and Cephalexin, while Cephalexin is the most resistant antibacterial drug for Escherichia Coli as compared with Amikacin and Nalidixic acid. https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/696E. Coli isolatesantibacterial activity. |
| spellingShingle | Saad B. Nashtar Adel . H Sheeh Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate مجله كليه طب الكندي E. Coli isolates antibacterial activity. |
| title | Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate |
| title_full | Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate |
| title_fullStr | Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate |
| title_full_unstemmed | Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate |
| title_short | Re-evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of Escherichia coli in al- najaf al- ashref governorate |
| title_sort | re evaluation of lunation of the activity of somantibacterial drugs against clinical isolates of escherichia coli in al najaf al ashref governorate |
| topic | E. Coli isolates antibacterial activity. |
| url | https://jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/696 |
| work_keys_str_mv | AT saadbnashtar reevaluationoflunationoftheactivityofsomantibacterialdrugsagainstclinicalisolatesofescherichiacoliinalnajafalashrefgovernorate AT adelhsheeh reevaluationoflunationoftheactivityofsomantibacterialdrugsagainstclinicalisolatesofescherichiacoliinalnajafalashrefgovernorate |